{
    "SPADE_UN_13485": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_13485",
            "Peptide Name": "Mastoparan-C (1-13)",
            "Source": "Synthetic construct",
            "Family": "Not found",
            "Gene": "N/A",
            "Sequence": "LNLKALLAVAKKI",
            "Sequence Length": 13,
            "UniProt Entry": [
                "http://www.uniprot.org/uniprot/P01516"
            ],
            "Protein Existence": "Protein level",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+",
                "Anti-Gram-"
            ],
            "Target Organism": "[Ref.33285267]Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC=64 µM); Bacillus subtilis ATCC 23857(MIC=16 µM);Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=16 µM); Pseudomonas aeruginosa ATCC 9027(MIC=32 µM); Klebsiella pneumoniae ATCC 700603(MIC=64 µM).",
            "Hemolytic Activity": "[Ref.33285267]0% hemolysis against mouse erythrocytes at 256 µM.",
            "Cytotoxicity": "No cytotoxicity information found in the reference(s) presented",
            "Binding Target": "liposomes",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Amidation",
            "Stereochemistry": "L",
            "Structure Description": "The CD spectra in water adopts a random-coil conformation,16.87% α-helix was determined in 50% TFE.",
            "Formula": "C66H123N17O15",
            "Mass": 1394.79,
            "PI": 10.3,
            "Net Charge": 3,
            "Hydrophobicity": 1.08,
            "Half Life": "Mammalian:5.5 hourYeast:3 minE.coli:2 min",
            "Function": "when combined with gentamicin, rifampin, and polymyxin B, it demonstrated synergistic or additive activity against E. coli ATCC 25922 and P. aeruginosa ATCC 9027.",
            "Literature": [
                {
                    "Title": "Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria.",
                    "Pubmed ID": "33285267",
                    "Reference": "Eur J Pharm Sci. 2021 Mar 1;158105665.",
                    "Author": "Zhu N, Zhong C, Liu T, Zhu Y, Gou S, Bao H, Yao J, Ni J.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=33285267"
                }
            ],
            "Frequent Amino Acids": "LAK",
            "Absent Amino Acids": "CDEFGHMOPQRSTUWY",
            "Basic Residues": 3,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 9,
            "Polar Residues": 8,
            "Positive Residues": 3,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_06005",
                    "Similarity": 1.0,
                    "Sequence": "LNLKALLAVAKKIL"
                },
                {
                    "SPADE_ID": "SPADE_UN_13465",
                    "Similarity": 1.0,
                    "Sequence": "CLNLKALLAVAKKILC"
                },
                {
                    "SPADE_ID": "SPADE_UN_13466",
                    "Similarity": 1.0,
                    "Sequence": "RKKRRQRRRLNLKALLAVAKKIL"
                }
            ]
        }
    }
}